Cardiovascular

Latest News
November 20th 2024

Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

November 15th 2024

How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

November 6th 2024

Work-Related Stress Linked to Poor Cardiovascular Health

October 24th 2024

Evaluating the American Heart Association’s PREVENT Equations: Enhancing CVD Risk Prediction

October 19th 2024

Fostering Interdisciplinary Communication: How Cardio-Renal-Metabolic Care Models Optimize Care Delivery

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Video Interviews
View All
September 25th 2024

Greater Awareness, Community Empowerment Needed in CVD Prevention Efforts

September 3rd 2024

Ochsner Health's Connected MOM Program: Managing Hypertension During Pregnancy and Postpartum

September 3rd 2024

CMS Negotiated Drug Prices: Cardiologist's View on Affordability, Future Innovation

August 26th 2024

Dr Martha Gulati Previews ESC 2024: Obesity, Heart Failure, and the Ongoing Debate on HRT

July 8th 2024

2024 ASPC Congress on CVD Prevention to Be Held in August

April 24th 2024

Dr Rashon Lane Addresses How Racial, Ethnic Inequities Factor Into Cardiometabolic Health Care

September 30th 2023

Lack of Cardiovascular Trial Diversity Is an International Issue: Dr Shrilla Banerjee Gives UK Perspective

September 20th 2023

Dr Donna Fitzsimons: “Doctor Knows Best” Mindset Wanes as Patients Become More Self-Educated

September 16th 2023

Dr Milind Desai on VALOR-HCM: Primary and Secondary Effects Are Sustained While on Mavacamten

September 5th 2023

Dr Milind Desai Highlights New Findings From VALOR-HCM Trial

Podcasts
View All
May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

May 10th 2022

For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management

February 22nd 2020

Podcast: This Week in Managed Care—Setbacks for Medicaid Work Rules and Other Health News

June 2nd 2019

Podcast: This Week in Managed Care—The $2 Million Gene Therapy and Other Health News

December 1st 2018

Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News

November 18th 2018

Podcast: This Week in Managed Care—Cancer Is the New Leading Cause of Death and Other Health News

November 10th 2018

Podcast: This Week in Managed Care—Medicaid Expansion at the Ballot Box and Other Health News

June 17th 2017

Podcast: This Week in Managed Care - Dropped ACA Coverage, and Other News

Continuing Medical Education
View All
November 21st 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology
November 21st 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
November 21st 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

"acute coronary syndrome" written on tablet | Image Credit: ibreakstock - stock.adobe.com
October 16th 2024

CHEST 2024 Posters Reveal Disparities in Acute Coronary Syndrome Care, Outcomes

Brooke McCormick
Two posters presented at the CHEST 2024 annual meeting highlighted significant disparities in acute coronary syndrome care and outcomes among different racial, ethnic, and gender groups, underscoring the urgent need for targeted interventions to address these inequities.
AJMC
October 10th 2024

Impact of Functional Recovery on Patients Having Heart Surgery

Richard J. Snow, DO, MPH Lauren McKown, JD, MPH Geoffrey Blossom, MD Karen Vogel, MPA Amy Creighton, MS Jason Shriver, OT Linda Will, APN Katie Lentz, PT, DPT Elizabeth Snow, MPH Teresa Caulin-Glaser, MD
This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.
doc measuring BP in pregnant woman-Andrey Popov-stock.adobe.com.jpeg
October 3rd 2024

Association Between Hypertensive Disorders of Pregnancy, Cardiovascular Severe Maternal Morbidity During Delivery Hospitalization

Pearl Steinzor
Hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome, and severe preeclampsia significantly elevate cardiovascular risk during delivery, study finds.
Measuring blood pressure | Image credit: Andrey Popov - stock.adobe.com
September 30th 2024

Stalled Progress in Reducing Black Mortality Rates: The Role of External Causes and COVID-19

Pearl Steinzor
Despite reductions in deaths from cancer and cardiovascular diseases, increased mortality from assaults, accidents, and the COVID-19 pandemic has widened disparities in health outcomes for Black individuals.
Woman holding hand to heart in pain | Image credit: eddows – stock.adobe.com
September 24th 2024

Largest Study of Lp(a), Recurrent ASCVD Highlights Critical Risks and Need for Screening

Hayden E. Klein
Higher levels of lipoprotein(a) (Lp[a]) were found to be associated with a continuously increasing risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events.
DNA double helix | Image credit: Dr_Microbe – stock.adobe.com
September 24th 2024

The Role of Genetics in Cholesterol, Heart Disease Risk

Hayden E. Klein
A collection of research by Helen Hobbs, MD, highlights how genetic mutations influence cholesterol levels and impact heart disease risk, offering insights into lifelong cardiovascular health management.
Homozygous familial hypercholesterolemia affects an estimated 1 in 300,000 individuals | image credit: iushakovsky - stock.adobe.com
September 24th 2024

A Silent Risk: The Critical Role of Awareness and Early Detection in Familial Hypercholesterolemia

Kyle Munz
September 24 celebrates Familial Hypercholesterolemia Awareness Day, which recognizes the importance of screening measures, education, and advocacy in a lesser-known, underdiagnosed cardiovascular condition.
Familial Hypercholesterolemia | Image credit: Richelle – stock.adobe.com
September 23rd 2024

A Decade of Progress in Familial Hypercholesterolemia Awareness, Treatment

Hayden E. Klein
On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing significant strides made in the field over the past decade.
Denver Colorado | Image Credit: © f11photo - stock.adobe.com
September 16th 2024

Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox

Christina Mattina
Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.
Family in hospital | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
September 9th 2024

Spouses, Relatives of Patients With GU Cancer Face Elevated Cardiovascular, Psychological Comorbidity Risks

Brooke McCormick
Spouses and first-degree relatives of patients with genitourinary (GU) cancers face increased risks of developing cardiovascular and psychological comorbidities, particularly within the first year of diagnosis.
Dr Ty Gluckman
September 5th 2024

Dr Ty J. Gluckman on Cardiovascular Prevention Barriers, Exciting Therapy Developments for 2025

Brooke McCormick
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) therapies.
Inclisiran's twice-yearly cadence and physician administration have potential to improve adherence to treatment, which is a common challenge with cholesterol management. Image credit: Robert - stock.adobe.com
August 30th 2024

Inclisiran Significantly Lowers LDL-C in V-MONO Study

Rose McNulty
Twice-yearly inclisiran (Leqvio) monotherapy showed clinically meaningful and statistically significant LDL-C lowering in patients at low or moderate risk of atherosclerotic cardiovascular disease in the V-MONO study.
Semaglutide Ozempic injection blood sugar obesity - myskin - stock.adobe.com.jpeg
August 26th 2024

Medicare Semaglutide Coverage: Millions May Gain Access That Could Cost $145 Billion

Giuliana Grossi
Medicare has not clearly defined what constitutes "established cardiovascular disease," leading to variability in potential patient eligibility; therefore, researchers aimed to estimate the number of Medicare beneficiaries who would become newly eligible for semaglutide under different definitions.
Human brain digital illustration | Image Credit: Siarhei - stock.adobe.com
August 14th 2024

Anti-Inflammatory Diet Linked to Lower Dementia Risk, Better Brain Health in Patients With Cardiometabolic Diseases

Brooke McCormick
Patients with cardiometabolic diseases who follow an anti-inflammatory diet have better brain health and a lower risk of dementia.
Joseph Biggio, MD, system chair and service line leader for women's services, and system chair for maternal fetal medicine at Ochsner Health
August 5th 2024

Ochsner Health Wins HHS Hypertension Innovator Award for Connected MOM Program

Pearl Steinzor
Ochsner Health's Connected Maternity Online Monitoring (MOM) program has been recognized for its innovative approach in managing hypertension during pregnancy and postpartum.
Cardiac CT scan | Image credit: Cleveland Clinic
August 3rd 2024

Using Imaging—and AI—to Find Those at Risk of Cardiac Events

Mary Caffrey
A joint session with the Society for Cardiovascular Computed Tomography (SCCT) took place on the first day of the American Society for Preventive Cardiology 2024 Congress in Salt Lake City, Utah.
AJMC Q&A with Dr Martha Gulati | Background image credit: ipopba – stock.adobe.com
August 2nd 2024

In ASPC President’s Address, Dr Martha Gulati Reflects on Progress and Future Goals in Cardiology

Hayden E. Klein
Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.
Michael Shapiro, DO, FASPC, Wake Forest University and ASPC president elect
July 31st 2024

ASPC Congress to Highlight Innovations in CVD Prevention

Maggie L. Shaw
In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.
concept of heart issues-ArtemisDiana-stock.adobe.com.jpeg
July 29th 2024

Applying PREVENT Equations May Reduce Statin and Antihypertensive Therapy for 15.8 Million US Adults

Pearl Steinzor
Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.
MedDiet on table | Image credit: monticellllo - stock.adobe.com
July 25th 2024

Mediterranean Diet May Optimize Heart Health Among Children, Adolescents

Pearl Steinzor
Interventions promoting adherence to the Mediterranean diet were associated with cardiometabolic biomarkers in children and adolescents, according to one study.
Patient using a smartwatch | Image Credit: sitthiphong - stock.adobe.com
July 20th 2024

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Brooke McCormick
Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
July 15th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Pearl Steinzor
No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).
Man investigating money with a magnifying glass | Image Credit: jirsak - stock.adobe.com
July 11th 2024

Study Finds Higher Health Care Expenditures for Patients With ASCVD, Diabetes

Brooke McCormick
Patients with both diabetes and atherosclerotic cardiovascular disease (ASCVD) have about 1.5 times higher total direct health care expenditures than those without diabetes.
Animated heart | Image Credit: - yodiyim - stock.adobe.com
July 4th 2024

GLP-1s Reduce Cardiovascular Risk Equally in Patients With Overweight, Obesity Regardless of Diabetes

Brooke McCormick
Glucagon-like peptide-1 (GLP-1) receptor agonists provide similar reductions in major adverse cardiovascular events, all-cause death, and cardiovascular-related death in patients with overweight and obesity who do not have diabetes and in patients with diabetes.
Air pollution | Image Credit: martin33 - stock.adobe.com
June 25th 2024

Air Pollution Linked to Increased Cardiovascular Disease Risk, Study Says

Brooke McCormick
Researchers discovered a causal relationship between air pollutants and increased cardiovascular disease (CVD) risk, highlighting the need for protective measures to mitigate exposure.
Health care cost concept | onephoto - stock.adobe.com
June 18th 2024

Home Heart Hospital Model Lowers Costs, Enhances Care for High-Cost Patients With CVD

Pearl Steinzor
The home-based care model offers a promising strategy for improving quality of care, while also reducing health care spending.
Hurricane damage to boats and shoreline | Macbeth GP - stock.adobe.com
June 12th 2024

How Climate Change Leads to Worse Cardiovascular Health

Pearl Steinzor
Extreme temperatures and hurricanes are strongly associated with worsening cardiovascular health, a study finds.
Xylitol sweetener | womue - stock.adobe.com
June 11th 2024

Sugar Substitute Xylitol Linked to Cardiovascular Risk

Pearl Steinzor
The low-calorie sweetener was associated with incident major adverse cardiovascular event risk, according to one study.
AJMC
June 10th 2024

Limited English Proficiency, Cardiovascular Risk Factors, Cardiovascular Disease, and In-Hospital COVID-19 Outcomes

Julia L. Berkowitz, MD Kevin F. Kennedy, MS Cristina Font, MD David R. Nerenz, PhD J. Dawn Abbott, MD Herbert D. Aronow, MD, MPH
This study evaluated whether limited English proficiency modifies the association between cardiovascular risk factors or cardiovascular disease and outcomes in patients hospitalized with COVID-19.
Magnesium pills | Image Credit: Dmitriy - stock.adobe.com
June 7th 2024

High Magnesium Depletion Scores Linked to Increased Mortality in US Patients With Hypertension

Brooke McCormick
Having a higher magnesium depletion score (MDS) independently predicts increased all-cause and cardiovascular mortality risks in US patients with hypertension (HTN), emphasizing the importance of early HTN prevention and magnesium deficiency management.
12345678
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo